Epilepsy Research
Volume 30, Issue 3 , Pages 203-217 , May 1998

Acute heat stress model of seizures in weanling rats: Influence of prototypic anti-seizure compounds

  • Gene C Palmer

      Affiliations

    • Astra Arcus USA, P.O. Box 20890, Rochester, NY 14602, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 716 2745575; fax: +1 716 2743910.
    • ,
  • Alfonso R Borrelli

      Affiliations

    • Astra Arcus USA, P.O. Box 20890, Rochester, NY 14602, USA
    • ,
  • Thomas J Hudzik

      Affiliations

    • Astra Arcus USA, P.O. Box 20890, Rochester, NY 14602, USA
    • ,
  • Sheldon Sparber

      Affiliations

    • University of Minnesota Medical School, Department of Pharmacology, 3249 Millard Hall, 435 Delaware Street SE, Minneapolis, MN 55455, USA

Received 17 June 1997 ,Revised 3 November 1997 ,Accepted 24 December 1997.

References 

  1. Ashton D, Wauquier A. Behavioral analysis of the effects of 15 anticonvulsants in the amygdaloid kindled rat. Psychopharmacology. 1979;65:7–13
  2. Baram TZ, Gerth A, Schultz L. Febrile seizures: An appropriate-aged model suitable for long-term studies. Dev. Brain Res. 1997;98:265–270
  3. Berg AT, Shinnar S. Complex febrile seizures. Epilepsia. 1996;37:126–133
  4. Chapman AG, Swan JH, Patel S, Graham JL, Meldrum BS. Cerebroprotective and anticonvulsant action of competitive and non-competitive NMDA antagonists. In:  Lubec G,  Rosenthal GA editor. Amino Acids: Chemistry, Biology and Medicine. Amsterdam: ESCOM Science; 1990;p. 219–232
  5. Freeman JM, Vining EPG. Febrile seizures: A decision-making analysis. Am. Fam. Phys. 1995;52:1401–1406
  6. Garske GE, Palmer GC, Napier JJ, Griffith RC, Freedman LR, Harris EW, et al. Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat. Epilepsy Res. 1991;9:161–174
  7. Gilbert ME. The NMDA-receptor antagonist, MK801, suppresses limbic kindling and kindled seizures. Brain Res. 1988;463:90–99
  8. Hudzik TJ, Palmer GC. Effects of anticonvulsants in a novel operant learning in rats: Comparison of remacemide hydrochloride and FPL 15896AR to other anticonvulsant agents. Epilepsy Res. 1995;21:183–193
  9. Hudzik TJ, Freedman L, Palmer GC. Remacemide hydrochloride and ARL 15896AR lack abuse potential: Additional differences from other uncompetitive NMDA antagonists. Epilepsia. 1996;37:544–550
  10. Hudzik, T.J., Borrelli, A.R., Palmer, G.C., 1997. Thermally-kindled seizures in weanling rats alters adult learning performance. Epilepsia, 38, Suppl. 8, 153.
  11. Jiang W, Duong T, de Lanerolle NC. Seizure duration and neuronal injury in hyperthermic seizures in rats. Soc. Neurosci. 1996;22:2084
  12. Johnston MV. Developmental aspects of epileptogenesis. Epilepsia Suppl. 1996;1:2–9
  13. Klauenberg BJ, Sparber SB. A kindling-like effect induced by repeated exposure to heated water in rats. Epilepsia. 1984;25:292–301
  14. Knudsen FU. Effective short-term diazepam prophylaxis in febrile convulsions. J. Pediatr. 1985;106:487–490
  15. Laorden ML, Carrillo E, Puig MM. Prevention of hyperthermia-induced convulsions in immature rat by MR-2266, a κ-antagonist. Methods Find. Exp. Clin. Pharmacol. 1991;13:605–608
  16. Lothman EW, Salerno RA, Perlin JB, Kaiser DL. Screening and characterization of antiepileptic drugs with rapidly recurring hippocampal seizures in rats. Epilepsy Res. 1988;2:367–379
  17. McCaughran JA, Manetto C, Schechter N. Long-term deficits in passive avoidance responding following experimental febrile convulsions during infancy. Behav. Brain Res. 1982;5:73–79
  18. McNamara JO, Russell RD, Rigsbee L, Bonhaus DW. Anticonvulsant and antiepileptogenic actions of MK801 in the kindling and electroshock models. Neuropharmacology. 1988;27:563–568
  19. Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates. Arch. Neurol. 1973;28:10–17
  20. Monaghan DT, Larsen H. NR1 and NR2 subunit contributions to N-methyl-d-aspartate receptor channel blocker pharmacology. J. Pharmacol. Exp. Ther. 1997;280:614–620
  21. Morimoto T, Nagao H, Yoshimatsu M, Yoshida K, Matsuda H. Pathogenic role of glutamate in hyperthermia-induced seizures. Epilepsia. 1993;34:447–452
  22. Ordy JM, Volpe B, Murray R, Thomas G, Bialobok P, Wengenack TM, et al. Pharmacological effects of remacemide and MK801 on memory and hippocampal CA1 damage in the rat four-vessel occlusion (4-VO) model of global ischemia. In:  Globus M,  Dietrich WD editor. The Role of Neurotransmitters in Brain Injury. New York: Plenum; 1992;p. 83–92
  23. Palmer GC, Hutchison JB. Preclinical and clinical aspects of remacemide hydrochloride. In:  Herrling P editors. Excitatory Amino Acids—Clinical Results with Antagonists (chapter 10). New York: Academic Press; 1997;p. 109–120
  24. Palmer GC, Murray RJ, Wilson TCM, Eisman MS, Ray RK, Griffith RC, et al. Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide. Epilepsy Res. 1992;12:9–20
  25. Palmer GC, Clark B, Hutchison JB. Antiepileptic and neuroprotective potential of remacemide hydrochloride. Drugs Future. 1993;18:1021–1042
  26. Palmer GC, Stagnitto ML, Garske GE, Napier JJ, Harris EW, Kaiser FC, et al. Anticonvulsant efficacy/safety properties of 2-amino-N-(1,2-diphenylethyl) acetamide hydrochloride. J. Pharmacol. Exp. Ther. 1995;273:1023–1031
  27. Pedder SCJ, Wilcox RI, Tuchek JM, Johnson DD. Attenuation of febrile seizures in epileptic chicks by N-methyl-d-aspartate receptor antagonists. Can. J. Physiol. Pharmacol. 1990;68:84–88
  28. Porter RHP, Greenamyre JT. Regional variations in the pharmacology of NMDA receptor channel blockers: Implications for therapeutic potential. J. Neurochem. 1995;64:614–623
  29. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972;32:281–294
  30. Rogawski MA. The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs. 1992;44:279–292
  31. Rogawski MA, Porter RJ. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 1990;42:224–286
  32. Sharma HS, Kretzschmar R, Cervos-Navarro J, Ermisch A, Ruhle H-J, Dey PK. Age-related pathophysiology of the blood-brain barrier in heat stress. Prog. Brain Res. 1992;91:189–196
  33. Silver JM, Shin C, McNamara JO. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann. Neurol. 1991;29:356–363
  34. Smith MC. Febrile seizures recognition and management. Drugs. 1994;47:933–944
  35. Sparber SB, Klauenberg BJ, Thomas LW. Heated water-induced convulsions: A model for studying the effects of early febrile convulsions and perinatal exposure or withdrawal from drugs upon the sensitivity of the CNS. Soc. Neurosci. 1994;20:505.10
  36. Stark LG, Peterson SL, Albertson TE. Pharmacological and toxicological evaluation of potential antiepileptic drugs in the kindling model of epilepsy. In:  Wada JA editors. Kindling. New York: Plenum; 1990;p. 267–281
  37. Subramaniam S, Donevan SD, Rogawski MA. Block of the N-methyl-d-aspartate receptor by remacemide and its des-glycine metabolite. J. Pharmacol. Exp. Ther. 1996;276:161–168
  38. Sutula T, Koch J, Golarai G, Watanabe Y, McNamara JO. NMDA receptor dependence of kindling and mossy fiber sprouting: Evidence that the NMDA receptor regulates patterning of hippocampal circuits in the adult brain. J. Neurosci. 1996;16:7398–7406
  39. Tsai M-L, Hung K-L. Risk factors for subsequent epilepsy after febrile convulsions. J. Med. Formosa Med. Assoc. 1995;94:327–331
  40. Werboff J, Havlena J. Febrile convulsions in infant rats, and later behavior. Science. 1963;142:684–685
  41. Willetts J, Balster RL, Leander JD. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci. 1990;11:423–428
  42. Williamson JM, Lothman EW. The effect of MK801 on kindled seizures: Implications for use and limitations as an antiepileptic drug. Ann. Neurol. 1989;26:85–90

PII: S0920-1211(98)00002-3

Epilepsy Research
Volume 30, Issue 3 , Pages 203-217 , May 1998

Article Tools

* Image Usage & Resolution